Beclomethasone Suppository
Compounded beclomethasone suppositories are a prescription-only corticosteroid formulation used to treat inflammatory conditions of the rectum and distal colon, such as ulcerative proctitis, radiation proctitis, and other localized inflammatory bowel diseases. Beclomethasone provides potent anti-inflammatory effects with minimal systemic absorption, making it ideal for patients who require localized relief without the side effects of oral steroids. These suppositories are administered rectally to reduce mucosal inflammation, bleeding, and discomfort. Our pharmacy compounds beclomethasone suppositories in provider-directed doses and hypoallergenic bases to support GI and colorectal treatment protocols.
Compounded beclomethasone suppositories are a prescription-only corticosteroid formulation used to treat inflammatory conditions of the rectum and distal colon, such as ulcerative proctitis, radiation proctitis, and other localized inflammatory bowel diseases. Beclomethasone provides potent anti-inflammatory effects with minimal systemic absorption, making it ideal for patients who require localized relief without the side effects of oral steroids. These suppositories are administered rectally to reduce mucosal inflammation, bleeding, and discomfort. Our pharmacy compounds beclomethasone suppositories in provider-directed doses and hypoallergenic bases to support GI and colorectal treatment protocols.
Compounded beclomethasone suppositories are a prescription-only corticosteroid formulation used to treat inflammatory conditions of the rectum and distal colon, such as ulcerative proctitis, radiation proctitis, and other localized inflammatory bowel diseases. Beclomethasone provides potent anti-inflammatory effects with minimal systemic absorption, making it ideal for patients who require localized relief without the side effects of oral steroids. These suppositories are administered rectally to reduce mucosal inflammation, bleeding, and discomfort. Our pharmacy compounds beclomethasone suppositories in provider-directed doses and hypoallergenic bases to support GI and colorectal treatment protocols.
